Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 4, Number 1—March 1998


Hantavirus Infection in Children in Argentina

Noemí C. Pini*, Amanda Resa†, Gladys del Jesús Laime‡, Gustavo Lecot¶, Thomas G. Ksiazek§, Silvana Levis*, and Delia A. Enria*
Author affiliations: *Instituto Nacional de Enfermedades Virales Humanas "Dr. Julio I Maiztegui," Pergamino, Argentina; †Hospital de El Bolsón, Río Negro, Argentina; ‡Hospital de Orán, Salta, Argentina; ¶Hospital de Olavarría, Buenos Aires, Argentina; §Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 2

Laboratory results and clinical features of children with hantavirus infection, Argentina, 1995–1997

Tests and features 1 2 3 4 5
(/mm3) 9,200 27,000 12,800 10,600 69,200
Hematocrit (%) 44 66 43 55 53
Thrombocytes (/mm3) NDa 266,000 200,000 97,000 ND
Sedimentation rate (mm/hr) ND 4 28 8 1
GOT/GPTb ND Increased Increased Increased Increased (mild)
Chest X-ray HIc DIId DII DII DII
Respiratory symptoms None Distress Slight dyspnea Tachypnea, clinical and X-ray disassociation, hypoventilation Acute respiratory insufficiency

aND: Not done.
bGOT/GPT: Glutamic oxalacetic transaminase/Glutamic pyruvic transaminase.
cHI: Hilar indistinctness.
dDII: Diffuse interstitial infiltrate.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO